Zobrazeno 1 - 10
of 108
pro vyhledávání: '"S E, Borisov"'
Publikováno v:
Фармакоэкономика, Vol 16, Iss 2, Pp 162-175 (2023)
Objective: analysis of clinical and economic efficiency of various etiotropic chemotherapy regimes in patients with respiratory tuberculosis with multidrug- and extensively drug-resistant (MDR and XDR) pathogen using the pharmacoeconomic modeling met
Externí odkaz:
https://doaj.org/article/ea1ef39601cd48b480cd3c23bceb4b9c
Autor:
A. I. Gayda, A. V. Abramchenko, M. I. Romanova, T. V. Toichkina, V. S. Burykhin, S. E. Borisov, A. V. Filippov, T. A. Kuznetsova, D. V. Perkhin, O. M. Sveshnikova, M. V. Lekhlyayder, A. M. Panteleev, S. V. Toinova, T. I. Maslennikova, D. O. Galakhova, L. N. Populyashina, G. I. Saenko, E. S. Anisimova, A. K. Svicharskaya, N. A. Sosova, O. V. Lovacheva, A. O. Maryandyshev, A. G. Samoylova
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 12, Pp 44-53 (2023)
The objective: to justify the optimal duration of chemotherapy with Lzd and Bdq by evaluating the long-term treatment outcomes in patients with multiple/pre-extensive drug resistant (MDR/preXDR) tuberculosis who interrupted treatment at different tim
Externí odkaz:
https://doaj.org/article/f351e9604c4949d6bfd983a255c59acd
Autor:
D. A. Ivanova, S. E. Borisov, O. V. Rodina, A. V. Filippov, T. N. Ivanushkina, N. V. Litvinova
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 1, Pp 5-15 (2020)
The objective: safety assessment of chemotherapy regimens compiled in accordance with the recommendations of World Health Organization (WHO), 2019, in patients with multiple drug resistant tuberculosis (MDR) in clinical practice settings.Subjects: Fr
Externí odkaz:
https://doaj.org/article/aa12cd277c6d40c095fe9452a38e9ac3
Autor:
M. A. Krasnova, E. M. Belilovsky, S. E. Borisov, A. A. Khakhalina, Yu. D. Mikhaylova, E. Yu. Nosova
Publikováno v:
Туберкулез и болезни лёгких, Vol 97, Iss 12, Pp 34-44 (2020)
The article describes a retrospective study of the results of microbiological and molecular genetic tests of 685 M. tuberculosis cultures isolated from 685 adult tuberculosis patients registered for dispensary follow-up in Moscow in 2014.The followin
Externí odkaz:
https://doaj.org/article/a570e3b1f6ad44629c80fe5fe03b8d41
Autor:
S. E. Borisov, A. V. Filippov, D. A. Ivanova, T. N. Ivanushkina, N. V. Litvinova, Yu. Yu. Garmash
Publikováno v:
Туберкулез и болезни лёгких, Vol 97, Iss 5, Pp 28-42 (2019)
The objective of the study: to determine the efficacy and safety of chemotherapy regimens with bedaquiline in patients with respiratory tuberculosis in the context of everyday clinical practice with minimal non-inclusion criteria. Subjects and method
Externí odkaz:
https://doaj.org/article/de55e12617c24932ac2d5136574da4a3
Autor:
A. G. Chuchalin, S. N. Avdeev, Z. R. Aisanov, O. P. Baranova, S. E. Borisov, N. A. Geppe, A. A. Vizel’, I. Yu. Vizel’, A. A. Zaicev, N. Y. Kravchenko, M. M. Ilkovich, O. V. Lovacheva, A. B. Malakhov, A. G. Malyavin, D. V. Petrov, V. V. Romanov, I. V. Sivokozov, M. V. Samsonova, I. P. Solovieva, I. E. Stepanyan, S. A. Terpigorev, I. E. Tyurin, L. Ya. Frantsuzevich, A. L. Chernyaev, E. I. Shmelev, N. M. Shmeleva
Publikováno v:
PULMONOLOGIYA. 32:806-833
Sarcoidosis is a multi-organ granulomatosis of unknown origin. Modern diagnostic methods allow detecting this disease at an early stage. The absence of specific markers requires a comprehensive approach to diagnosis based on comparison of radiation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5210feb4dfa986661430684e0b8db30
https://doi.org/10.18093/0869-0189-2022-32-6-806-833
https://doi.org/10.18093/0869-0189-2022-32-6-806-833
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 5, Pp 6-13 (2018)
The article presents the data on the prevalence of tuberculosis in the penitentiary units in the countries of the WHO European Region compared to theRussian Federation.It lists factors providing an impact on the risk of the disease and notification r
Externí odkaz:
https://doaj.org/article/f1b1ed121d0f4744b3d487cf62c74425
Autor:
S. E. Borisov, E. M. Bogorodskaya, G. V. Volchenkov, E. V. Kulchavenya, A. O. Maryandyshev, S. N. Skornyakov, O. B. Talibov, A. M. Tikhonov, I. A. Vasilyeva
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 3, Pp 6-18 (2018)
The objective of the study: to assess efficiency and safety of SQ109 used within standard treatment regimens for multiple drug resistant tuberculosis (MDR TB)Subjects and Methods A multi-center, double, blind, randomized, placebo-controlled study was
Externí odkaz:
https://doaj.org/article/95f3ca114ed944d7826a17058873f5b0
Autor:
D. A. Ivаnovа, S. E. Borisov
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 2, Pp 47-54 (2018)
The objective of the study: to define indications for discontinuation of a drug causing adverse reactions during chemotherapy in tuberculosis patients. The frequency, severity, and outcomes of adverse reactions with anti-tuberculosis drugs discontinu
Externí odkaz:
https://doaj.org/article/1ce1cee741604de48be3fd100633ee0b
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 11, Pp 5-17 (2017)
The article presents information on the prevalence of tuberculosis with MDR/RR/XDR in different countries and the WHO regions in comparison with the Russian Federation, given in the WHO Global Reports on Tuberculosis, and the interpretation and syste
Externí odkaz:
https://doaj.org/article/5bcc450e97cd4bd1a27054aedc154d4c